Policy, Organisation and Incentives in Health Systems
Health system policies should incentivise high-quality health care in areas of highest need at the lowest feasible cost. Our aim is to expand our understanding of policies that result in healthier populations and achieve sustainability while being responsive to patients’ needs.
Green Healthcare: Are We Asking the Right Questions?
11 September 2024
The climate-health crisis is a growing global concern, and identifying the right starting points is crucial.
Adult vaccination programmes deliver socio-economic benefits up to 19 times initial investment, according to new report
18 April 2024
Our new report examines the promise of prevention in healthcare and provides six key recommendations that could usher in a new era of optimised prevention.
Efficiency and Labour Productivity of Primary Care in England
14 March 2024
The Office of Health Economics (OHE) has conducted a multi-year research programme funded by the Health Foundation on the efficiency of general practices in England and…
Developing a Conceptual Framework of Healthcare System Pressure
13 February 2024
The term ‘pressure’ has been widely used to describe various challenges, long before the COVID-19 pandemic. Regardless of its common usage, a formal definition of healthcare system pressure (HCSP) is currently missing.
Looking Further Afield – What Can Health Economics Learn from the Environmental Economics Approach to Discounting?
1 February 2024
Discounting in economic evaluations presents challenges for therapies with high up-front costs and long-term benefits. We discuss how health economics can learn from debates occurring within environmental economics, where discounting poses similar challenges.
The Socioeconomic Burden Of Cervical Cancer in the UK: What are the benefits of achieving the WHO elimination target?
24 January 2024
Cervical cancer imposes a substantial burden on patients, their support networks, the NHS, and society at large. This report underscores the significant socioeconomic savings that can be achieved by reaching the WHO’s elimination goal of 4 cases per 100,000 women, providing further impetus to take action to reach the ambitious 2040 elimination target set by NHS England.
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
The first 10 drugs included in the Medicare Drug Price Negotiation Program created by the Inflation Reduction Act (IRA) were announced at the end of August. We discuss what they are, what they show us, and the potential ripple effects.
Capturing the Broader Value of Antibiotics
23 November 2023
The value of antibiotics often extends beyond what HTA captures. The STEDI framework aims to capture that broader value and our report outlines a roadmap to realising its full potential.
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
Learn more about how the topic of sustainability was tackled by a broad range of speakers and the key themes which emerged.